Hackstein, Carl-Philipp http://orcid.org/0000-0002-0821-5204
Costigan, Dana
Drexhage, Linnea http://orcid.org/0000-0001-7679-4466
Pearson, Claire http://orcid.org/0000-0001-5816-1657
Bullers, Samuel
Ilott, Nicholas http://orcid.org/0000-0002-8432-8622
Akther, Hossain Delowar
Gu, Yisu
FitzPatrick, Michael E. B. http://orcid.org/0000-0003-2365-2012
Harrison, Oliver J. http://orcid.org/0000-0003-1515-9586
Garner, Lucy C. http://orcid.org/0000-0002-6461-252X
Mann, Elizabeth H. http://orcid.org/0000-0001-8339-2094
Pandey, Sumeet
Friedrich, Matthias
Provine, Nicholas M. http://orcid.org/0000-0002-9694-2216
Uhlig, Holm H. http://orcid.org/0000-0002-6111-7355
Marchi, Emanuele
Powrie, Fiona http://orcid.org/0000-0003-3312-5929
Klenerman, Paul http://orcid.org/0000-0003-4307-9161
Thornton, Emily E. http://orcid.org/0000-0002-0068-2502
Funding for this research was provided by:
Wellcome Trust (222426/Z/21/Z, 095688/Z/11/Z, 212240/Z/18/Z, 222426/Z/21/Z, 095688/Z/11/Z, 212240/Z/18/Z)
Leona M. and Harry B. Helmsley Charitable Trust
Article History
Received: 24 February 2022
Accepted: 20 November 2022
First Online: 3 December 2022
Competing interests
: F.P. received consultancy or research support from GSK, Novartis, Janssen, Genentech, and Roche. H.H.U. has received research support or consultancy fees from Janssen, UCB Pharma, Eli Lilly, AbbVie, Celgene, OMass, and MiroBio. P.K. has done consultancy for UCB and Medimab. The remaining authors declare no competing interests.